Bullying in adolescents across three years in the context of the COVID-19 pandemic: a repeated cross-sectional and prospective analysis.

Bullying in adolescents across three years in the context of the COVID-19 pandemic: a repeated cross-sectional and prospective analysis.

Publication date: Jan 15, 2025

Bullying has been identified as a risk factor for many issues among adolescents. Although it was already considered a public health issue in Brazil before the COVID-19 pandemic, little is known about how the pandemic and associated public health measures have affected bullying behavior. To explore changes in bullying victimization and perpetration among Brazilian high school students from 2019 to 2022. This study utilizes data from the Longitudinal Study of Adolescent Lifestyle (ELEVA), employing a repeated cross-sectional with a nested cohort design. Adolescents (n = 1. 987, 50. 2% female, mean age 16. 4 years) answered a questionnaire and bullying-related information were extracted from two different questions for victims and perpetrators. Multilevel logistic regression models were used. Bullying victimization decreased from 46% (95% CI: 40-52%) in 2019 to 30% (95% CI: 24-36%) in 2022 (OR: 0. 46, 95% CI: 0. 30-0. 69, p 

Open Access PDF

Concepts Keywords
Brazil Bullying perpetration
Bullying Bullying victimization
Models Longitudinal studies
Pandemic
Schools

Semantics

Type Source Name
disease MESH Bullying
disease MESH COVID-19 pandemic
disease MESH Lifestyle
pathway REACTOME Reproduction
drug DRUGBANK Coenzyme M
disease MESH Obesity
disease MESH loneliness
disease MESH anxiety
drug DRUGBANK Ethanol
disease MESH infection
drug DRUGBANK L-Valine
disease MESH violence
drug DRUGBANK Adenosine
drug DRUGBANK Ademetionine
drug DRUGBANK Etoperidone
drug DRUGBANK O1-Methyl-4-Deoxy-4-Thio-Beta-D-Glucose
disease IDO process
disease MESH causes
disease IDO intervention
disease MESH depressive symptoms
drug DRUGBANK Trestolone
drug DRUGBANK Fosfomycin
disease MESH social stigma
disease IDO susceptibility
disease MESH Hards
drug DRUGBANK Ribostamycin
disease IDO role
disease MESH suicide
drug DRUGBANK Tretamine
drug DRUGBANK Cyclic Adenosine Monophosphate
drug DRUGBANK Ranitidine

Original Article

(Visited 2 times, 1 visits today)

Leave a Comment

Your email address will not be published. Required fields are marked *